Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Modern utilization of penile prosthesis surgery: a national claim registry analysis

Abstract

The objective of this study was to evaluate the modern utilization of penile prosthesis surgery based on data derived from national claim databases and contrast to an analysis of patients similarly treated at an academic center during a contemporaneous period. A retrospective claim analysis utilizing a national database (MarketScan, Thomson Reuters) was performed for Commercial insurer and Medicare databases between January 2000 and March 2011. A retrospective analysis of contemporaneous penile prosthesis implantation at the Johns Hopkins Hospital (JHH) was done. Population demographics, comorbidities, previous (ED) therapies and time from ED diagnosis to surgery were assessed. Median ages for patients undergoing penile prosthesis implantation were 58, 70 and 63 years for the Commercial, Medicare and JHH cohorts, respectively. For the claim databases (Commercial, Medicare, respectively), hypertension (72%, 78%), dyslipidemia (71%, 56%) and diabetes mellitus (45%, 40%) were predominant comorbidities, whereas for the JHH database prostate cancer (51%) and its management by prostatectomy (45%) or radiation (12%) were predominant. Previous use of PDE5 inhibitors was similar across databases (60, 58 and 69% for Commercial, Medicare and JHH cohorts, respectively), although previous use of non-oral ED therapies was greater in the JHH database. Median time to surgery from initial ED diagnosis was 2, 2 and 4 years for the Commercial, Medicare and JHH patients, respectively. Demographic variables and ED risk factors associated with penile prosthesis surgery at a national population-based level over a contemporary period were defined. Some differences in utilization trends of penile prosthesis surgery exist at a single institutional level.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  2. Teles AG, Carreira M, Alarcão V, Sociol D, Aragüés JM, Lopes L et al. Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 Portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study. J Sex Med 2008; 5: 1317–1324.

    Article  Google Scholar 

  3. Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ et al. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 2007; 4: 1269–1276.

    Article  Google Scholar 

  4. Aytac IA, McKinlay JB, Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–56.

    Article  Google Scholar 

  5. Carvalheira AA, Pereira NM, Maroco J, Forjaz V . Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med 2012; 9: 2361–2369.

    Article  Google Scholar 

  6. Turner LA, Althof SE, Levine SB, Tobias TR, Kursh ED, Bodner D et al. Treating erectile dysfunction with external vacuum devices: impact upon sexual, psychological and marital functioning. J Urol 1990; 144: 79–82.

    Article  CAS  Google Scholar 

  7. Derouet H, Caspari D, Rohde V, Rommel G, Ziegler M . Treatment of erectile dysfunction with external vacuum devices. Andrologia 1999; 31 (Suppl 1): 89–94.

    PubMed  Google Scholar 

  8. Prabhu V, Alukal JP, Laze J, Makarov DV, Lepor H . Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction. J Urol 2013; 189: 238–242.

    Article  Google Scholar 

  9. Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP . A review of outcomes of an intracavernosal injection therapy programme. BJU Int 2012; 110: 1787–1791.

    Article  CAS  Google Scholar 

  10. Mydlo JH, Volpe MA, MacChia RJ . Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int 2000; 86: 469–473.

    Article  CAS  Google Scholar 

  11. Salonia A, Gallina A, Zanni G, Briganti A, Dehò F, Saccà A et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 53: 564–570.

    Article  Google Scholar 

  12. Schultheiss D, Gabouev AI, Jonas U, Nikolaj A . Bogoraz (1874-1952): pioneer of phalloplasty and penile implant surgery. J Sex Med 2005; 2: 139–146.

    Article  Google Scholar 

  13. Morales PA, Suarez JB, Delgado J, Whitehead ED . Penile implant for erectile impotence. J Urol 1973; 109: 641–645.

    Article  CAS  Google Scholar 

  14. Male reproductive health. In: Litwin MS, Saigal CS (eds). Urologic Diseases in America. US Government Printing Office: Washington, DC, USA, 2012, pp 405-444.

  15. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  Google Scholar 

  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373–383.

    Article  CAS  Google Scholar 

  17. Wolters U, Wolf T, Stützer H, Schröder T . ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77: 217–222.

    Article  CAS  Google Scholar 

  18. Henry GD, Kansal NS, Callaway M, Grigsby T, Henderson J, Noble J et al. Centers of excellence concept and penile prostheses: an outcome analysis. J Urol 2009; 181: 1264–1268.

    Article  Google Scholar 

  19. Ulmer WD, Prasad SM, Kowalczyk KJ, Gu X, Dodgion C, Lipsitz S et al. Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol 2012; 188: 775–780.

    Article  Google Scholar 

  20. Barocas DA, Gray DT, Fowke JH, Mercaldo ND, Blume JD, Chang SS et al. Racial variation in the quality of surgical care for prostate cancer. J Urol 2012; 188: 1279–1285.

    Article  Google Scholar 

  21. Anderson CB, Penson DF, Ni S, Makarov DV, Barocas DA . Centralization of radical prostatectomy in the United States. J Urol 2013; 189: 500–506.

    Article  Google Scholar 

  22. Tal R, Jacks LM, Elkin E, Mulhall JP . Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J Sex Med 2011; 8: 1797–1804.

    Article  Google Scholar 

  23. Lotan Y, Roehrborn CG, McConnell JD, Hendin BN . Factors influencing the outcomes of penile prosthesis surgery at a teaching institution. Urol 2003; 62: 918–921.

    Article  Google Scholar 

  24. Cortés-Gonzalez JR, Glina S . Have phosphodiesterase-5 inhibitors changed the indications for penile implants? BJU Int 2009; 103: 1518–1521.

    Article  Google Scholar 

  25. Chung E, Van CT, Wilson I, Cartmill RA . Penile prosthesis implantation for the treatment of male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures. World J Urol 2013; 31: 591–595.

    Article  CAS  Google Scholar 

  26. Salonia A, Ferrari M, Sacca A, Pellucchi F, Castagna G, Clementi MC et al. Delay in seeking medical help in patients with new-onset erectile dysfunction remained high over and despite the PDE5 era-an ecological study. J Sex Med 2012; 9: 3239–3246.

    Article  Google Scholar 

  27. Menard J, Tremeaux JC, Faix A, Pierrevelcin J, Staerman F . Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with vasculogenic erectile dysfunction. J Sex Med 2011; 8: 3479–3486.

    Article  Google Scholar 

  28. Wiser H, Kottwitz M, Wilson S, Kohler T . Interesting Trends in Penile Prosthesis Usage. Presented at the 2013 Annual Meeting of the American Urological Association: San Diego, California, USA, 2013.

    Google Scholar 

Download references

Acknowledgements

We thank Angela M. Ginkel, of American Medical Systems, Inc. (AMS), Minnetonka, MN, for editorial review support, and Zhaoyong Feng and Dr Bruce J. Trock, Division of Epidemiology, Brady Urological Institute for assistance with statistical methodology and analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A L Burnett.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Segal, R., Camper, S. & Burnett, A. Modern utilization of penile prosthesis surgery: a national claim registry analysis. Int J Impot Res 26, 167–171 (2014). https://doi.org/10.1038/ijir.2014.11

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2014.11

This article is cited by

Search

Quick links